Illumina, Inc. And ReaMetrix, Inc. USA To Collaborate On Molecular Diagnostics And Market Development

SAN DIEGO & SAN CARLOS, Calif.--(BUSINESS WIRE)--July 20, 2006--Illumina, Inc. (NASDAQ: ILMN - News) and ReaMetrix, Inc. announced today the formation of a diagnostic collaboration under which the companies plan to co-develop molecular diagnostic panels for a range of disease areas. Under the terms of the agreement, ReaMetrix will gain non-exclusive rights to market the resulting panels to the country of India and its more than one billion inhabitants. Illumina will retain rights to market the tests outside of India.

Back to news